I About
Intelligencia AI uses curated biomedical data and machine learning to predict the probability of technical and regulatory success for drugs in clinical trials, helping pharma de-risk development. Founded in 2017 (New York HQ, Athens office) by Dimitrios Skaltsas and Vangelis Vergetis; ~110 staff.
Focus Areas
Technology Focus
healthcare ai drug discovery
Key People 2
- Dimitrios Skaltsas
- Vangelis Vergetis
Quick Stats
- Total Raised
- $17M
- Founded
- 2017
- Status
- private
- Type
- commercial
Explore More
Similar Companies
Ranked by shared focus areas, technology, and location.
Tempus AI
Chicago, United States
82%
2 shared categories
2 shared AI types
Healthcare AIDrug Discovery
Xaira Therapeutics
San Francisco, United States
82%
2 shared categories
2 shared AI types
Drug DiscoveryHealthcare AI
Verge Genomics
San Francisco, United States
82%
2 shared categories
2 shared AI types
Drug DiscoveryHealthcare AI
BPGbio
Framingham, United States
82%
2 shared categories
2 shared AI types
Drug DiscoveryHealthcare AI